106 related articles for article (PubMed ID: 212568)
1. Genetic analyses of differences in incidence of mammary tumors and reticulum cell neoplasms with the use of recombinant inbred lines of mice.
Dux A; Mühlbock O; Bailey DW
J Natl Cancer Inst; 1978 Oct; 61(4):1125-9. PubMed ID: 212568
[TBL] [Abstract][Full Text] [Related]
2. Inter-strain graft-vs.-host disease T-cell responses to immunodominant minor histocompatibility antigens.
Korngold R; Leighton C; Mobraaten LE; Berger MA
Biol Blood Marrow Transplant; 1997 Jun; 3(2):57-64. PubMed ID: 9267665
[TBL] [Abstract][Full Text] [Related]
3. T cell subsets involved in lethal graft-versus-host disease directed to immunodominant minor histocompatibility antigens.
Berger M; Wettstein PJ; Korngold R
Transplantation; 1994 Apr; 57(7):1095-102. PubMed ID: 7909395
[TBL] [Abstract][Full Text] [Related]
4. The effect of the Cmv-1 resistance gene, which is linked to the natural killer cell gene complex, is mediated by natural killer cells.
Scalzo AA; Fitzgerald NA; Wallace CR; Gibbons AE; Smart YC; Burton RC; Shellam GR
J Immunol; 1992 Jul; 149(2):581-9. PubMed ID: 1378069
[TBL] [Abstract][Full Text] [Related]
5. Loss of heterozygosity occurs via mitotic recombination in Trp53+/- mice and associates with mammary tumor susceptibility of the BALB/c strain.
Blackburn AC; McLary SC; Naeem R; Luszcz J; Stockton DW; Donehower LA; Mohammed M; Mailhes JB; Soferr T; Naber SP; Otis CN; Jerry DJ
Cancer Res; 2004 Aug; 64(15):5140-7. PubMed ID: 15289317
[TBL] [Abstract][Full Text] [Related]
6. Autogenous antibodies against the murine mammary tumor virus in strains of mice with low incidences of mammary tumors.
Michalides R; Wagenaar E; Nusse R
J Natl Cancer Inst; 1979 Apr; 62(4):935-41. PubMed ID: 219283
[TBL] [Abstract][Full Text] [Related]
7. Kinetics of responses to tumor antigens and mouse mammary tumor virus in BALB/cCrgl and BALB/cfC3H mice.
Lopez DM; Sigel MM; Charyulu VL
J Natl Cancer Inst; 1981 Jan; 66(1):191-6. PubMed ID: 6256573
[TBL] [Abstract][Full Text] [Related]
8. Immunodominance in the graft-vs-host disease T cell response to minor histocompatibility antigens.
Korngold R; Wettstein PJ
J Immunol; 1990 Dec; 145(12):4079-88. PubMed ID: 2258608
[TBL] [Abstract][Full Text] [Related]
9. Comparative studies of purified subviral component vaccines and formalin-treated mammary tumor viruses from four inbred strains of mice.
Girardi AJ; Dion AS; Pomenti AA; Holben JA
J Natl Cancer Inst; 1985 Feb; 74(2):405-13. PubMed ID: 2983136
[TBL] [Abstract][Full Text] [Related]
10. Induction of endogenous mammary tumor virus expression during hormonal induction of mammary adenoacanthomas and carcinomas of BALB/c female mice.
McGrath CM; Prass WA; Maloney TM; Jones RF
J Natl Cancer Inst; 1981 Oct; 67(4):841-52. PubMed ID: 6268884
[TBL] [Abstract][Full Text] [Related]
11. Multiple genetic factors in the MHC and predominant role of D-end in the resistance against C3H-MTV-induced mammary tumors.
Dux A
Transplant Proc; 1983 Dec; 15(4):2101-3. PubMed ID: 6324428
[No Abstract] [Full Text] [Related]
12. Impact of ionizing radiation and genetic background on mammary tumorigenesis in p53-deficient mice.
Backlund MG; Trasti SL; Backlund DC; Cressman VL; Godfrey V; Koller BH
Cancer Res; 2001 Sep; 61(17):6577-82. PubMed ID: 11522657
[TBL] [Abstract][Full Text] [Related]
13. A new locus (Mtv-4) for endogenous mammary tumor virus expression and early mammary tumor development in the SHN mouse strain.
Imai S; Tsubura Y; Hilgers J; Michalides R
J Natl Cancer Inst; 1983 Sep; 71(3):517-21. PubMed ID: 6310199
[TBL] [Abstract][Full Text] [Related]
14. Immunodominant CD4+ T cell receptor Vbeta repertoires involved in graft-versus-host disease responses to minor histocompatibility antigens.
Berger MA; Korngold R
J Immunol; 1997 Jul; 159(1):77-85. PubMed ID: 9200441
[TBL] [Abstract][Full Text] [Related]
15. Immunologic studies with mouse mammary tumor viruses: comparative studies with spontaneous mammary tumor cell vaccines from five inbred mouse strains.
Girardi AJ; Dion AS; Holben JA
J Natl Cancer Inst; 1985 Jan; 74(1):105-12. PubMed ID: 2982052
[TBL] [Abstract][Full Text] [Related]
16. Alterations of acquired mouse mammary tumor virus DNA during mammary tumorigenesis in BALB/cfC3H mice.
Cardiff RD; Morris DW; Young LJ
J Natl Cancer Inst; 1983 Nov; 71(5):1011-9. PubMed ID: 6316008
[TBL] [Abstract][Full Text] [Related]
17. Expression of mammary tumor virus proteins in preneoplastic outgrowth lines and mammary tumors of BALB/cV mice.
Slagle BL; Lanford RE; Medina D; Butel JS
Cancer Res; 1984 May; 44(5):2155-62. PubMed ID: 6324998
[TBL] [Abstract][Full Text] [Related]
18. Mouse strain (STS/A) resistant to mammary tumor induction by hypophysial isografts.
van der Gugten AA; Röpcke G; van Nie R; Hilgers J
Cancer Res; 1985 Aug; 45(8):3448-53. PubMed ID: 4016729
[TBL] [Abstract][Full Text] [Related]
19. Reevaluation of the effect of mouse mammary tumor virus infection on the BALB/c mouse hyperplastic outgrowth.
Ashley RL; Cardiff RD; Fanning TG
J Natl Cancer Inst; 1980 Nov; 65(5):977-86. PubMed ID: 6253710
[TBL] [Abstract][Full Text] [Related]
20. Variations in genetic control of susceptibility to Theiler's murine encephalomyelitis virus (TMEV)-induced demyelinating disease. I. Differences between susceptible SJL/J and resistant BALB/c strains map near the T cell beta-chain constant gene on chromosome 6.
Melvold RW; Jokinen DM; Knobler RL; Lipton HL
J Immunol; 1987 Mar; 138(5):1429-33. PubMed ID: 3027179
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
